The feasibility study of TAS-118 plus Oxaliplatin or TAS-118 monotherapy as perioperative chemotherapy for locally advanced gastric cancer
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur/folinic acid (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- Acronyms APOLLO-11
- 12 Sep 2017 Trial design of the study presented at the 42nd European Society for Medical Oncology Congress.
- 06 Dec 2016 Status changed from not yet recruiting to recruiting.
- 11 Nov 2016 New trial record